Nadège Lucas

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Placebo Controlled

Postmenopausal Women

Top Venues

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Istvan Takacs, Emese Mezősi, Alfonso Soto, Peter Kamenickỷ, Marie-Lucile Figueres, Maria Angeles Galvez Moreno, Sandrine Lemoine, Françoise Borson-Chazot, Ismael Capel, Taha Ouldrouis, Nadège Lucas, Soraya Allas, Mark Sumeray, Michel Ovize, Michael Mannstadt
An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism. The Journal of clinical endocrinology and metabolism 109 (9) (2024)
Istvan Takacs, Emese Mezősi, Alfonso Soto, Peter Kamenickỷ, Marie-Lucile Figueres, Maria Angeles Galvez Moreno, Sandrine Lemoine, Françoise Borson-Chazot, Ismael Capel, Taha Ouldrouis, Nadège Lucas, Soraya Allas, Mark Sumeray, Michel Ovize, Michael Mannstadt
An Open-Label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism. The Journal of clinical endocrinology and metabolism (2024)